Diabetes Worldwide: WHO Data

✓ Medically reviewed | Published: | Evidence level: 1A
The World Health Organization reports that diabetes affects hundreds of millions of people worldwide and directly causes well over a million deaths each year. Large pooled analyses show a substantial share of adults with diabetes are not receiving treatment, making access to diagnosis, medicines and lifestyle support a central public health challenge.
📅 Published:
✓ Reviewed by iMedic Medical Editorial Team
📄 Public Health

Quick Facts

Adults With Diabetes
Over 800 million
Direct Deaths (WHO)
About 1.6 million yearly
Main Type
Type 2 majority

How Common Is Diabetes Around the World?

Quick answer: Diabetes affects more than 800 million adults worldwide, and prevalence has risen sharply over recent decades, especially in low- and middle-income countries.

A major pooled analysis by the NCD Risk Factor Collaboration, published in The Lancet in 2024, estimated that more than 800 million adults were living with diabetes in 2022, roughly four times the number recorded in 1990. The increase reflects population growth and ageing, but also rising rates of overweight and obesity, physical inactivity and diets high in refined carbohydrates and ultra-processed foods. Most cases are type 2 diabetes, in which the body becomes resistant to insulin or cannot produce enough to keep blood glucose in range.

The WHO states that diabetes directly caused roughly 1.6 million deaths in 2021, and that many more deaths are linked to the cardiovascular and kidney disease that high blood glucose accelerates. Complications include heart attack, stroke, kidney failure, nerve damage, vision loss and lower-limb amputation. Many people live for years with undiagnosed type 2 diabetes, which is why screening is emphasized by health agencies.

Why Do Many People With Diabetes Go Untreated?

Quick answer: Gaps in screening, medicine affordability and health system capacity mean a large proportion of adults with diabetes, particularly in lower-income settings, do not receive effective treatment.

The same Lancet analysis found that a large proportion of adults with diabetes, in the range of more than half, were not taking medication, with the gap being widest in parts of sub-Saharan Africa and South Asia. Barriers include cost of insulin and oral agents, limited availability of glucose monitoring, shortage of trained primary care staff and low awareness of symptoms. Even in wealthy countries, many patients do not reach recommended targets for blood glucose, blood pressure and cholesterol.

The WHO has responded with the Global Diabetes Compact, launched in 2021, which aims to improve prevention, diagnosis and care and to widen access to essential medicines including insulin. Core prevention advice centres on maintaining a healthy weight, regular physical activity, a diet rich in whole foods and avoiding tobacco. For people with prediabetes, structured lifestyle programmes have been shown in randomized trials such as the US Diabetes Prevention Program to substantially lower progression to type 2 diabetes. Newer medicines, including GLP-1 based drugs, are expanding treatment options, but affordability remains a key concern.

Frequently Asked Questions

Frequent urination, excessive thirst, unexplained weight loss, fatigue and blurred vision are typical. Type 2 diabetes can also be symptom-free for years, so screening is important for people at higher risk.

In many people it can be delayed or prevented. Evidence from trials like the Diabetes Prevention Program shows that modest weight loss and regular physical activity substantially reduce risk in people with prediabetes.

Type 1 is an autoimmune condition in which the body stops producing insulin and requires lifelong insulin therapy. Type 2 involves insulin resistance and reduced insulin production and is often linked to weight and lifestyle factors.

References

  1. World Health Organization. Diabetes fact sheet.
  2. NCD Risk Factor Collaboration. Worldwide trends in diabetes prevalence and treatment from 1990 to 2022. The Lancet. 2024.
  3. World Health Organization. Global Diabetes Compact.